Dengue vaccines

Clinical trials for Dengue vaccines explained in plain language.

Never miss a new study

Get alerted when new Dengue vaccines trials appear

Sign up with your email to follow new studies for Dengue vaccines, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1 Completed 1

Retrospective analysis of passive safety surveillance data of dengue vaccine, qdenga (TAK 003) at private vaccination centers, during 2023 and 2024 dengue season in buenos aires, argentina

Completed

The TAK-003 vaccine, Qdenga, developed by Takeda, was approved by ANMAT in April 2023 and has been available in Argentina since November 2023 for individuals from 4 years old and without limit of age. Clinical trials demonstrate that Qdenga has a favorable safety profile, adequat…

Matched conditions: DENGUE VACCINES

Sponsor: Fundación Vacunar

Last updated Sep 10, 2026 16:00 UTC

Dengue vaccines

Get alerted when new Dengue vaccines trials appear

Retrospective analysis of passive safety surveillance data of dengue vaccine, qdenga (TAK 003) at private vaccination centers, during 2023 and 2024 dengue season in buenos aires, argentina